Prognosis after cystectomy not affected by smoking

October 15, 2012
Prognosis after cystectomy not affected by smoking
Despite the link between cigarette smoking and the development of bladder cancer, the prognosis of people with bladder cancer after undergoing a cystectomy is not affected by cigarette smoking, according to research published online Oct. 8 in Urology.

(HealthDay)—Despite the link between cigarette smoking and the development of bladder cancer, the prognosis of people with bladder cancer after undergoing a cystectomy is not affected by cigarette smoking, according to research published online Oct. 8 in Urology.

In an effort to determine the effect of cigarette smoking on recurrence-free, cancer-specific, and overall survival, Chunwoo Lee, M.D., of the Asan Medical Center in Seoul, , and colleagues conducted a study involving 602 patients who had undergone radical cystectomy for bladder cancer.

The researchers found that, overall, 340 people had smoked and 159 were current smokers. For smokers and nonsmokers, the five-year recurrence-free survival rates were 62.1 and 56.8 percent, respectively. The five-year cancer-specific were 67.3 and 63.9 percent for smokers and nonsmokers, respectively. Finally, the five-year overall survival rate was 63.0 percent for smokers and 58.8 percent for nonsmokers. None of these between-group differences were statistically significant.

"The results of the present study suggest that smoking history is not a significant for the survival of operable patients with after radical cystectomy," the authors write. "However, it was not possible to ascertain whether smoking and the ensuing effects precluded some patients from undergoing radical cystectomy to begin with."

Explore further: Improved radical surgery techniques provide positive outcomes for bladder cancer patients

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Improved radical surgery techniques provide positive outcomes for bladder cancer patients

August 8, 2011
Bladder cancer patients who have radical surgery at university hospitals can benefit from excellent local control of the disease, acceptable clinical outcomes and low death rates, according to research in the August issue ...

Cigarette smoking implicated in half of bladder cancers in women

August 16, 2011
Current cigarette smokers have a higher risk of bladder cancer than previously reported, and the risk in women is now comparable to that in men, according to a study by scientists from the National Cancer Institute (NCI), ...

Chemo - radiation best for bladder cancer, study finds

April 19, 2012
(HealthDay) -- The addition of two well-tolerated chemotherapy drugs to radiation therapy led to significantly longer survival rates among patients with muscle-invasive bladder cancer.

Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer

May 17, 2012
For some patients with muscle-invasive bladder cancer, treatment may begin before they undergo cystectomy, or surgical removal of the bladder. They may be advised by oncologists to receive chemotherapy before surgery. A large ...

Recommended for you

Study prompts new ideas on cancers' origins

December 16, 2017
Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the ...

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.